Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease.
Central nervous system (CNS) hemangioblastoma is the most common manifestation of von Hippel-Lindau (VHL) disease. It is found in 70-80% of VHL patients. Hemangioblastoma is a rare form of benign vascular tumor of the CNS, accounting for 2.0% of CNS tumors. It can occur sporadically or as a familial syndrome. CNS hemangioblastomas are typically located in the posterior fossa and the spinal cord. VHL patients usually develop a CNS hemangioblastoma at an early age. Therefore, they require a special routine for diagnosis, treatment and follow-up. The surgical management of symptomatic tumors depend on many factors such as symptom, location, multiplicity, and progression of the tumor. The management of asymptomatic tumors in VHL patients are controversial since CNS hemangioblastomas grow with intermittent quiescent and rapid-growth phases. Preoperative embolization of large solid hemangioblastomas prevents perioperative hemorrhage but is not necessary in every case. Radiotherapy should be reserved for inoperable tumors. Because of complexities of VHL, a better understanding of the pathological and clinical features of hemangioblastoma in VHL is essential for its proper management.
Department of Neurosurgery, Yokohama City University School of Medicine; Department of Neurosurgery, Yokosuka City Hospital, Yokosuka, Japan.
Hiroshi
H
Kanno
Department of Neurosurgery, Yokohama City University School of Medicine; Department of Neurosurgery, Yokosuka City Hospital, Yokosuka, Japan.
Natsuki
N
Kobayashi
Department of Neurosurgery, Yokohama City University School of Medicine; Department of Neurosurgery, Yokosuka City Hospital, Yokosuka, Japan.
Satoshi
S
Nakanowatari